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Objectives: To estimate the prevalence of Familial Hyperlipidemia (FH) in a 
population of the Colombian Caribbean affiliated with Colombian Public Health 
Insurance Company (PHIC) and project this estimate to the population of the 
Colombian Caribbean. Methods: Data on a history of hyperlipidemia was collected 
by study investigators at including adults patients affiliated with PHIC (64,667) with 
ICD-10 diagnosis of hyperlipidemia (E78), or with a personal history of 
hyperlipidemia; or with abnormal lipid profile; or patients under treatment with lipid-
lowering drugs. Data on personal or family history of premature coronary artery 
disease (CAD), presence of xanthomas and family history of FH were included. 
FHHe corresponded to LDL-C .190 mg/dL (5 mmol/L) for adults and/or with 1 first-
degree relative similarly affected or with CAD. FHHo corresponded to LDL-C .500 
mg/dL (13 mmol/ L) or LDL-C .300 mg/dL (8 mmol/L) under treatment with statins 
and/or 1 or both parents having clinically diagnosed FH. For the projection of the 
estimated prevalence of FH to the population of the Colombian Caribbean, the data 
of the adult population projections for the Colombian Caribbean of 2015 (general 
10,442,134, adults 6,685,734) of the Departamento Administrativo Nacional de 
Estadisticas (DANE) were used. Results: If we assume that 1 of 5 patients with 
LDL-C .190 mg/dL (5 mmol/L) may have HF. The prevalence of patients with FH 
was 0.13% (87/64,667). The prevalence of adults with heterozygous FH (FHHe) 
was 0.13% (85/64,639). The prevalence of adults with homozygous HF (FHHo) 
was 0.0015% (1/64,639). Applying these estimates to the general population of 
Colombian Caribbean in 2015, the estimated number of cases of HF, FHHe and 
FHHo in the Caribbean Colombian could be approximately 13,574, 8,691 and 140, 
respectively. Conclusions: The estimated prevalence of FH, FHHe and FHHo in 
Colombian Caribbean was 1 of 769, 1 of 769 and 2 of 100,000 patients, 
respectively 
